Anixa Biosciences, Inc. (ANIX)
$2.66-0.37%Close
SELLCRISIS · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $91M
- Beta
- 0.60
- P/E (TTM)
- -8.70
- Short % float
- 4.19%
- Days to cover
- 3.7
- SI change
- +28.0%
- 1W
- -9.83%
- 1M
- -1.12%
- vs SPY 1W
- -9.69%
- vs SPY 1M
- -3.62%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on ANIX?
- LOPJLB’s latest quantitative signal on Anixa Biosciences, Inc. (ANIX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ANIX in?
- Anixa Biosciences, Inc. (ANIX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Anixa Biosciences, Inc. (ANIX) do?
- Anixa Biosciences, Inc. (ANIX) is a biotechnology company dedicated to pioneering therapies and vaccines. Its core mission revolves around addressing critical, unmet medical needs, particularly within the fields of oncology (cancer) and infectious diseases. Among its therapeutic pipeline, Anixa is developing a novel chimeric endocrine receptor T-cell (CER-T) technology, an innovative adaptation…